The expression of ARHI in pT2a and pT2b stage gastric cancer and its clinical significance

By Wang Wei   Bu Xian-Min   Wang Jian   Zhang Ning   Zhao Cheng-Hai  

Oncology Reports, Vol. 27, Iss. 6, 2012-06 ,pp. : 1953-1959

Spandidos Publications

Access to resources Recommend Favorite

Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2- neu -positive breast cancer? A current debate

By Petrelli Fausto  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 401-408

Humana Press, Inc

Access to resources Recommend Favorite

Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group

By Oshita Takafumi   Itamochi Hiroaki   Nishimura Ryuichiro   Numa Fumitaka   Takehara Kazuhiro   Hiura Masamichi   Tanimoto Hirotoshi   Noma Jun   Hayase Ryoji   Murakami Akihiro   Fujimoto Hideo   Kanamori Yasunobu   Kitada Fuminori   Shitsukawa Keiji   Nagaji Makoto   Minagawa Yukihisa   Fujiwara Michihisa   Kigawa Junzo  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1107-1113

Springer Publishing Company

Access to resources Recommend Favorite

CD151 Overexpression is Associated with Poor Prognosis in Patients with pT3 Gastric Cancer

By Ha Sang   Do In-Gu   Lee Jeeyun   Park Se   Park Joon   Kang Won   Choi Min-Gew   Lee Jun   Bae Jae   Kim Sung   Kim Kyoung-Mee   Sohn Tae  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1099-1106

Springer Publishing Company

Access to resources Recommend Favorite

The Efficacy of Intravesical Bacillus Calmette-Guerin in the Treatment of Patients with pT1 Stage Non-muscle-invasive Bladder Cancer

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 4, 2013-08 ,pp. : 278-283

Informa Healthcare

Access to resources Recommend Favorite